↓ Skip to main content

Thrombosis and Embolism: from Research to Clinical Practice

Overview of attention for book
Thrombosis and Embolism: from Research to Clinical Practice
Springer International Publishing

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 100 The Prevention of Venous Thromboembolism in Surgical Patients
  3. Altmetric Badge
    Chapter 101 Thromboembolic Prophylaxis for Morbidly Obese Patients Undergoing Bariatric Surgery
  4. Altmetric Badge
    Chapter 102 The Use of Surgical Care Improvement Projects in Prevention of Venous Thromboembolism
  5. Altmetric Badge
    Chapter 103 The Diagnosis and Management of Early Deep Vein Thrombosis
  6. Altmetric Badge
    Chapter 104 Symptomatology, Clinical Presentation and Basic Work up in Patients with Suspected Pulmonary Embolism
  7. Altmetric Badge
    Chapter 105 Radionuclide Diagnosis of Pulmonary Embolism
  8. Altmetric Badge
    Chapter 106 Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism
  9. Altmetric Badge
    Chapter 107 Surgical Treatment of Acute Massive Pulmonary Embolism
  10. Altmetric Badge
    Chapter 108 The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism
  11. Altmetric Badge
    Chapter 109 Anticoagulation Therapy in Patients with Chronic Kidney Disease
  12. Altmetric Badge
    Chapter 110 Cancer-Associated Thrombosis: Regulatory Mechanisms and Emerging Directions
  13. Altmetric Badge
    Chapter 111 The Treatment of Venous Thromboembolism in Patients with Cancer
  14. Altmetric Badge
    Chapter 112 The Role of New Oral Anticoagulants (NOACs) in Cancer Patients
  15. Altmetric Badge
    Chapter 113 Venous Thromboembolic Disease in Children and Adolescents
  16. Altmetric Badge
    Chapter 114 Deep Vein Thrombosis in Intensive Care
  17. Altmetric Badge
    Chapter 115 Cerebral Venous Thrombosis
  18. Altmetric Badge
    Chapter 116 Endovascular Treatment of Thrombosis and Embolism
  19. Altmetric Badge
    Chapter 117 Venous Thromboembolism in Brain Tumor Patients
  20. Altmetric Badge
    Chapter 118 Portal Vein Thrombosis: Recent Advance
  21. Altmetric Badge
    Chapter 119 Portal Vein Thrombosis After Splenic and Pancreatic Surgery
  22. Altmetric Badge
    Chapter 120 Genetic Risk Factors in Venous Thromboembolism
  23. Altmetric Badge
    Chapter 121 Venous and Arterial Thrombosis: Is There a Link?
  24. Altmetric Badge
    Chapter 122 Thrombosis and von Willebrand Factor
  25. Altmetric Badge
    Chapter 123 Role of P2Y12 Receptor in Thrombosis
  26. Altmetric Badge
    Chapter 124 Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs
  27. Altmetric Badge
    Chapter 125 The Risk of Thromboembolism in Users of Antidepressants and Antipsychotics
  28. Altmetric Badge
    Chapter 126 Post Thrombotic Syndrome
  29. Altmetric Badge
    Chapter 128 A Review of the Evidence to Support Neuromuscular Electrical Stimulation in the Prevention and Management of Venous Disease
  30. Altmetric Badge
    Chapter 129 Non-Invasive Management of Peripheral Arterial Disease
  31. Altmetric Badge
    Chapter 130 Medico-Legal Aspects of Pulmonary Thromboembolism
Attention for Chapter 112: The Role of New Oral Anticoagulants (NOACs) in Cancer Patients
Altmetric Badge

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
The Role of New Oral Anticoagulants (NOACs) in Cancer Patients
Chapter number 112
Book title
Thrombosis and Embolism: from Research to Clinical Practice
Published in
Advances in experimental medicine and biology, September 2016
DOI 10.1007/5584_2016_112
Pubmed ID
Book ISBNs
978-3-31-922107-6, 978-3-31-922108-3
Authors

Raveena Ravikumar, Chung Sim Lim, Alun Huw Davies

Editors

Md. Shahidul Islam

Abstract

New oral anticoagulants (NOACs) are likely to have a major impact in the next few years, changing clinical practice of anticoagulation therapy. Evidence on its efficacy and superiority to vitamin K antagonists (VKAs) in treating non-cancer patients have been reported in a few clinical trials. However, patients with cancer are complicated by the prothrombotic nature of the disease, need for potentially invasive surgery and interventions, and altered drug handling. This chapter examines the available evidence and guidelines on the use of NOAC in patients with cancer.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 14%
Student > Ph. D. Student 4 11%
Student > Bachelor 3 8%
Researcher 2 6%
Student > Postgraduate 2 6%
Other 4 11%
Unknown 16 44%
Readers by discipline Count As %
Medicine and Dentistry 12 33%
Pharmacology, Toxicology and Pharmaceutical Science 3 8%
Nursing and Health Professions 1 3%
Business, Management and Accounting 1 3%
Sports and Recreations 1 3%
Other 1 3%
Unknown 17 47%